Work

A Phase 1/2 Study of INCB000928 As Monotherapy or Combined with Ruxolitinib (RUX) in Patients (Pts) with Anemia Due to Myelofibrosis (MF)

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-169210

Authors: Sanjay R Mohan, Stephen T Oh, Haris Ali, Anthony M. Hunter, Francesca Palandri, Betty Lamothe, Yi Cui, Francis Seguy, Amanda McBride, Michael Robert Savona, Jean-Jacques Kiladjian, Srdan Verstovsek

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Washington University in St. Louis, City Of Hope National Medical Center, Emory University, Istituto di Ematologia di Bologna, Incyte (United States), Vanderbilt University Medical Center, Hôpital Saint-Louis, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310124866

FWCI: 0.621

Cites:

Cited by: 4

Related to: 10